J 2023

Hypertension treatment in patients with sleep apnea from the European Sleep Apnea Database (ESADA) cohort - towards precision medicine

SVEDMYR, Sven, Jan HEDNER, Maria Rosaria BONSIGNORE, Carolina LOMBARDI, Gianfranco PARATI et. al.

Basic information

Original name

Hypertension treatment in patients with sleep apnea from the European Sleep Apnea Database (ESADA) cohort - towards precision medicine

Authors

SVEDMYR, Sven (guarantor), Jan HEDNER, Maria Rosaria BONSIGNORE, Carolina LOMBARDI, Gianfranco PARATI, Ondřej LUDKA (203 Czech Republic, belonging to the institution), Ding ZOU and Ludger GROTE

Edition

Journal of Sleep Research, HOBOKEN, WILEY, 2023, 0962-1105

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30210 Clinical neurology

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 4.400 in 2022

RIV identification code

RIV/00216224:14110/23:00130273

Organization unit

Faculty of Medicine

UT WoS

000899297400001

Keywords in English

antihypertensive treatment; beta-blocker; blood pressure control; diuretic; hypertension; obstructive sleep apnea

Tags

Tags

International impact, Reviewed
Změněno: 15/11/2023 07:41, Mgr. Tereza Miškechová

Abstract

V originále

We recruited 5,970 patients with hypertension with obstructive sleep apnea (OSA) on current antihypertensive treatment from the European Sleep Apnea Database (ESADA) cohort. The group was subdivided into those receiving monotherapy (n = 3,594) and those receiving dual combined therapy (n = 2,376). We studied how major OSA confounders like age, gender, and body mass index as well as the degree of sleep apnea modified office systolic and diastolic blood pressure. Beta-blockers alone or in combination with a diuretic were compared with other antihypertensive drug classes. Monotherapy with beta-blocker was associated with lower systolic blood pressure, particularly in non-obese middle-aged males with hypertension. Conversely, the combination of a beta-blocker and a diuretic was associated with lower systolic and diastolic blood pressure in patients with hypertension with moderate-severe OSA. Systolic blood pressure was better controlled in female patients using this combined treatment. Our cross-sectional data suggest that specific clinical characteristics and type of antihypertensive medication influence the degree of blood pressure control in patients with hypertension with OSA. Controlled trials are warranted.